Clik here to view.
Provision Healthcare的ProNova SC360质子治疗系统获得FDA核准
田纳西州诺克斯维尔 (美国商业资讯) — Provision Healthcare的研发和制造分支ProNova Solutions的SC360质子治疗系统已获得FDA 510(k)核准，该核准距研发启动仅有4年时间。这是首台也是唯一一台能够从所有角度治疗患者而无需移动患者的紧凑型360度笔尖束扫描质子治疗系统，实现了最高效的临床工作流程，提高了治疗精度和患者舒适性。...
View ArticleClik here to view.
New statement from European Crohn’s and Colitis Organisation supports...
INCHEON, South Korea Celltrion Healthcare welcomes the publication of the latest position paper from the European Crohn’s and Colitis Organisation (ECCO) on the use of biosimilars for inflammatory...
View ArticleClik here to view.
Alvogen Launches the First Generic Equivalent to Tamiflu® Capsules in the...
PINE BROOK, N.J. Today, Alvogen has launched the first generic equivalent to Tamiflu® (oseltamivir phosphate) capsules in the United States. Alvogen expects the generic equivalent to Tamiflu®...
View ArticleClik here to view.
神経栄養性角膜炎：ドンペが提出したCenegermin点眼薬（Oxervate®）の市販承認申請をEMAが受理
ミラノ — （ビジネスワイヤ） — バイオ医薬品企業のドンペは、欧州医薬品庁（EMA）に提出した点眼薬Oxervate®の登録申請が受理されたと発表しました。Oxervate®は中等度および重度の神経栄養性角膜炎の成人患者を治療する医薬品です。...
View ArticleClik here to view.
美商寰泰的产品现已在中国发售
中国广州 (美国商业资讯) — 致力于改变生活、创造更美好世界的全球性健康和保健公司美商寰泰(Mannatech®, Incorporated, NASDAQ: MTEX)今天宣布，该公司已通过一个提供独特在线零售购物体验的跨境电子商务网站www.MeiTaiChina.com，向中国大陆发售该公司的数款创新优质营养补充剂产品。 Smart News...
View ArticleClik here to view.
Mannatech’s Products Now Available in China
GUANGZHOU, China Mannatech®, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced that it has made several of its...
View ArticleClik here to view.
プロビジョン・ヘルスケアがProNova SC360陽子線治療システムのFDA承認を取得
米テネシー州ノックスビル （ビジネスワイヤ） — プロビジョン・ヘルスケアの子会社として研究・開発・製造を手掛けるプロノーバ・ソリューションズは、SC360陽子線治療システムの研究開発を開始してわずか4年で、FDAから...
View ArticleClik here to view.
アルボジェンが米国でタミフルカプセルと等価の初の後発医薬品をリリース
米ニュージャージー州パインブルック （ビジネスワイヤ） — 本日、アルボジェンは米国でタミフル（オセルタミビルリン酸塩）カプセルと等価の初の後発医薬品をリリースしました。アルボジェンでは、これから来るシーズンの間、患者と医療提供者にとって最大5億ドルの大幅節約を実現しながら、タミフルカプセルと等価の後発医薬品を提供できると見込んでいます。本製品は3種の含量（30 mg、45 mg、75...
View ArticleClik here to view.
Alvogen在美国上市Tamiflu®胶囊的首个等效仿制药
新泽西州PINE BROOK (美国商业资讯) – 今天，Alvogen在美国上市Tamiflu®（磷酸奥司他韦）胶囊的首个等效仿制药。Alvogen预计，在这个即将到来的季节中，Tamiflu®胶囊的等效仿制药能为患者和医疗提供者节约最高达5亿美元。该产品有3种规格（30毫克、45毫克和75毫克）。 Smart News Releases（智能新闻稿）是一个多媒体平台。在此处查看完整新闻稿：...
View ArticleClik here to view.
韦伦氏集团为赢创(Evonik)收购Huber的二氧化硅业务提供咨询服务
伦敦 (美国商业资讯)–韦伦氏集团(The Valence Group)已为赢创(Evonik)以6.3亿美元收购J.M.Huber的二氧化硅（亦称“硅石”）业务提供咨询服务。...
View ArticleClik here to view.
Clik here to view.
Vyome Presents on the Development of the Dual Action Rational Therapeutics...
NEW DELHI Vyome Biosciences, a clinical-stage specialty biopharmaceutical company developing novel medicines for treating diseases caused by drug-resistance in the skin microbiome, will present two...
View ArticleClik here to view.
Mannatech Brings Ambrotose® Powders to China with Launch of Cross-Border...
GUANGZHOU, China Mannatech®, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, announced its cross-border e-commerce launch in...
View ArticleClik here to view.
美商寰泰凭借跨境电子商务业务的开通在中国上市Ambrotose®粉
中国广州 (美国商业资讯) — 致力于改变生活、创造更美好世界的全球性健康和保健公司美商寰泰(Mannatech®, Incorporated, NASDAQ: MTEX)宣布在中国开通跨境电子商务，在亚洲市场上市15款新产品，包括Ambrotose粉。临床显示，美商寰泰的创新醣质营养Ambrotose补充剂粉可提供认知支持，包括改善成人专注力、注意力和记忆力，这些是学业和事业成功的关键因素。...
View ArticleClik here to view.
Acucela Secures Option to Exclusively Acquire Novel Retinal Technology
SEATTLE Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596) that specializes in identifying and...
View ArticleClik here to view.
KYOCERA Optical Blood-Flow Sensor Is Among World’s Smallest for Wearable...
KYOTO, Japan Kyocera Corporation (NYSE:KYO)(TOKYO:6971) announced that it has developed one of the smallest known optical blood-flow sensors, which measures the volume of blood flow in subcutaneous...
View ArticleClik here to view.
GI Dynamics, Inc. Announces Completion of A$1.5 Million Private Placement and...
BOSTON & SYDNEY GI Dynamics®, (ASX:GID) a medical technology company that has developed an innovative device to improve outcomes for patients diagnosed with type 2 diabetes and obesity is...
View ArticleClik here to view.
Pfizer and Astellas Announce Top-Line Results from Phase 4 PLATO Trial of...
NEW YORK & TOKYO Pfizer Inc. (NYSE:PFE) and Astellas Pharma Inc. (TSE:4503) today announced the Phase 4 PLATO study, evaluating the efficacy and safety of continued treatment with XTANDI®...
View ArticleClik here to view.
Baxter to Expand Portfolio of Essential Generic Injectable Medicines with...
DEERFIELD, Ill. Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today entered into a definitive agreement to acquire Claris Injectables Limited,...
View ArticleClik here to view.
Gyros Protein Technologies and Abacus ALS Sign Distribution Agreement
UPPSALA, Sweden Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today that it has appointed...
View Article